Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Menzies

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Trends in Cognitive Sciences|July 12, 2002
Joint explorationsPaul P. Wang, Heng Da Cheng, Anna Menzies
Pathology|August 10, 2023
FIP1L1::PDGFRA fusion driving three synchronous haematological malignanciesMichael Krigstein, Anna Menzies, Keith Fay, et al.
European Journal of Haematology|July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapiesEric Wenlong Li, Esther Jones, Christian Bryant, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Trends in Cognitive Sciences|July 12, 2002
Joint explorationsPaul P. Wang, Heng Da Cheng, Anna Menzies
Pathology|August 10, 2023
FIP1L1::PDGFRA fusion driving three synchronous haematological malignanciesMichael Krigstein, Anna Menzies, Keith Fay, et al.
European Journal of Haematology|July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapiesEric Wenlong Li, Esther Jones, Christian Bryant, et al.
Pageof 1